Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001283303-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Jan 31, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
99,245
Total Value
$230,461.00
P&L
+inf% (+$2,552,180.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer and GC | Common Stock | โ | Jan 31, 2026 | Grant/Award | 25,110 | $0.00 | $0.00 | 115,380 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Feb 3, 2026 | Sale | 7,175 | $32.12 | $230,461.00 | 108,205 | Direct | โ | View Details | |
Chief Legal Officer and GC | Employee stock option (right to buy) | Derivative | Jan 31, 2026 | Grant/Award | 66,960 | $0.00 | $0.00 | 66,960 | Direct | โ | View Details |